For the Patient: GIA Other Names: Palliative chemotherapy for cancer of the liver (hepatoma) using Doxorubicin

Similar documents
For the Patient: Epirubicin Other names: PHARMORUBICIN

For the Patient: Amsacrine Other names: AMSA PD

For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct.

For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine

For the Patient: Mitoxantrone Other names:

For the Patient: LUSCTOP

For the Patient: Paclitaxel Other names: TAXOL

For the Patient: LUPUPE (Carboplatin Option)

For the Patient: Doxorubicin pegylated liposomal Other names: CAELYX, DOXIL, PLD

For the Patient: GIPE Palliative therapy of neuroendocrine tumours using Cisplatin and Etoposide

For the Patient: Eribulin Other names: HALAVEN

For the Patient: SAAJAP

For the Patient: LUAJPC

For the Patient: Methotrexate Other names: MTX

For the Patient: Bendamustine Other names: TREANDA

For the Patient: GIAVPG Other Names: First-line palliative chemotherapy for advanced gallbladder and bile duct cancer using Gemcitabine and Cisplatin

For the Patient: ULUAVPMTN

For the Patient: LUAVPP (Carboplatin Option)

For the Patient: LUSCPE

For the Patient: Trastuzumab emtansine Other names: KADCYLA

For the Patient: LUAVNP

For the Patient: LUPUPE

For the Patient: LUAVPEM

For the Patient: Protocol LUAJNP Other names: Adjuvant Treatment of Non-Small Cell Lung Cancer with Cisplatin and Vinorelbine

For the Patient: LUSCCAV

For the Patient: Fludarabine injection Other names: FLUDARA

For the Patient: Cyclosporine injection Other names: SANDIMMUNE I.V.

For the Patient: GIAVPANI Other Names: Palliative third line treatment of metastatic cancer of the colon or rectum using Panitumumab

ABOUT THIS MEDICATION

For the Patient: HNAVFUP Treatment for Advanced Squamous Cell Cancer of the Head and Neck using Fluorouracil and Platinum

For the Patient: LUOTPAC

For the Patient: LUAVPG (Carboplatin Option)

What are these drugs used for? Paclitaxel and carboplatin are intravenous anticancer medications used for many types of cancer.

ABOUT THIS MEDICATION

U = Undesignated GI = GastroIntestinal AJ = Adjuvant RALOX = Raltitrexed, Oxaliplatin

For the Patient: Cobimetinib tablets Other names: COTELLIC

For the Patient: Ponatinib Other names: ICLUSIG

For the Patient: LUAVPP

For the Patient: PROTOCOL SMAVTMZ Other Names: Palliative Therapy for Malignant Melanoma with Brain Metastases Using Temozolomide

For the Patient: GDP-R Other names: LYGDPR

For the Patient: LUAVPG

For the Patient: GOOVDDCAT

For the Patient: GOOVCATM

For the Patient: GOOVCATR

ABOUT THIS MEDICATION What are these drugs used for? Docetaxel is an anticancer drug used to treat cancers in the area of the neck and throat.

For the Patient: GIENACTRT Treatment of esophageal and gastroesophageal cancer, prior to surgery, using Carboplatin, Paclitaxel and Radiation Therapy.

For the Patient: Sunitinib Other names: SUTENT

For the Patient: Rituximab injection Other names: RITUXAN

For the Patient: Everolimus tablets Other names: AFINITOR

ABOUT THIS MEDICATION What is this drug used for? Gemcitabine is an intravenous anticancer medication used for some types of cancer.

For the Patient: ACTW Other names: BRAJACTW

For the Patient: LUAVDC

Nilotinib (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth.

For the Patient: Alemtuzumab SC injection Other names: MABCAMPATH, CAMPATH

For the Patient: UGINETEV Other Names: Treatment of advanced neuroendocrine tumours of gastrointestinal origin (Non-Functional) using Everolimus

Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth.

For the Patient: LULAPERT

For the Patient: Neoadjuvant therapy for locally advanced breast cancer using weekly paclitaxel followed by doxorubicin and cyclophosphamide

For the Patient: GIPAVCAP Other Names: Second line treatment of metastatic or unresectable pancreatic adenocarcinoma using Capecitabine

For the Patient: Lenvatinib Other names: LENVIMA

ABOUT THIS MEDICATION

For the Patient: Olaparib tablets Other names: LYNPARZA

For the Patient: Lenalidomide Other names: REVLIMID

For the Patient: Adjuvant therapy for breast cancer using weekly paclitaxel and trastuzumab (Herceptin)

GI = GastroIntestinal FOLFIRI = Folinic Acid, Fluorouracil, Irinotecan

For the Patient: GOCXCATB

For the Patient: GUBEP

For the Patient: GIPAJGCAP Other Names: Adjuvant chemotherapy for pancreatic adenocarcinoma using Gemcitabine and Capecitabine

You are being asked to take octreotide as a treatment to manage the symptoms of your cancer.

Treatment Plan: Drugs:

ABOUT THIS MEDICATION

ABOUT THIS MEDICATION

= GastroIntestinal Gastric (stomach) = Advanced = Fluorouracil, Folinic Acid, OXaliplatin ABOUT THIS MEDICATION

This therapy is being given to treat your cancer of the anal canal with the intention of cure.

ABOUT THIS MEDICATION

For the Patient: ACD

For the Patient: USMAVTRA Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Trametinib

For the Patient: GIAVTZCAP Other Names: Palliative therapy of metastatic neuroendocrine cancer of the pancreas, using Temozolomide and Capecitabine

For the Patient: GIAJCAPOX Other Names: Adjuvant combination chemotherapy for Stage III and IIB colon cancer using capecitabine and oxaliplatin.

For the Patient: DC. D Docetaxel (TAXOTERE ) C Cyclophosphamide

For the Patient: GICART Other Names: Curative therapy for cancer of the anal canal using combined Mitomycin, Capecitabine and Radiation Therapy

For the Patient: LYEPOCHR Other Names: DA-EPOCHR

For the Patient: UMYLDREL

What are these drugs used for? Irinotecan, fluorouracil (5FU), leucovorin and bevacizumab are drugs given to treat colon or rectal cancer.

What are these drugs used for? Irinotecan, fluorouracil (5FU), leucovorin, and panitumumab are drugs given to treat metastatic colorectal cancer.

GI = GastroIntestinal FIRINOX = Fluorouracil, Irinotecan, Infusional fluorouracil, Oxaliplatin

For the Patient: Afatinib Other names: GIOTRIF, GILOTRIF

For the Patient: GIRCRT Adjuvant therapy for high risk cancer of the rectum with combined Capecitabine and Radiation Therapy

ABOUT THIS MEDICATION

For the Patient: CAP. Capecitabine. Uses:

What are these drugs used for? Oxaliplatin, bevacizumab and capecitabine are drugs given to treat cancer of the colon or rectum.

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

For the Patient: Vemurafenib Other names: ZELBORAF

For the Patient: GUPDOCADT

INTENDED BENEFITS You are being asked to take these drugs as a treatment to reduce the risk of recurrence of cancer of the stomach or esophagus.

For the Patient: USMAVFIPI

For the Patient: ULUAVPMB

For the Patient: USMAVNIV

Docetaxel (Taxotere )

Transcription:

For the Patient: GIA Other Names: Palliative chemotherapy for cancer of the liver (hepatoma) using Doxorubicin GI = GastroIntestinal A = ADRIAMYIN (also known as doxorubicin) ABOUT THIS MEDIATION What is this drug used for? Doxorubicin is a drug given to treat cancer of the liver (also known as hepatoma ). It is given directly into the vein, or intravenously (IV). How does this drug work? Doxorubicin works by interfering with dividing cells and preventing an increase in the number of cancer cells. INTENDED BENEFITS This therapy is being given to destroy and/or limit the growth of cancer cells in your body. This treatment may improve your current symptoms, and delay the onset of new symptoms. It may take several treatments before your doctor can judge whether or not this treatment is helping. TREATMENT SUMMARY How is this drug given? You will receive one intravenous (IV) chemotherapy drug called doxorubicin. It is a liquid and appears naturally as the colour red. It will be given to you at the clinic by a chemotherapy nurse. Each treatment will take about 20 minutes. Your first treatment will probably take longer, as the nurse will review information on the chemotherapy drug with you. The treatment is followed by a 20 day rest period. This 3 week or 21-day period of time is called a cycle. The cycle may be repeated up to 3 or even 6 cycles, but may be changed depending on how the chemotherapy affects you. The calendar below outlines how your medication is given each 3 week cycle. Y L E 1 DATE TREATMENT PLAN Week 1 Doxorubicin IV x 1 day Week 2 No Treatment Week 3 No Treatment B ancer Agency Protocol Summary (Patient Version) GIA 1/5

Y L E 2 DATE TREATMENT PLAN Week 1 Doxorubicin IV x 1 day Week 2 No Treatment Week 3 No Treatment Treatment is continued for a maximum of 6 cycles, as long as you are benefitting from treatment and not having too many side effects. What will happen when I get my drugs? A blood test is done each cycle, on or before the first day of each treatment cycle. The dose and timing of your chemotherapy may be changed based on your blood counts and/or other side effects. SIDE EFFETS AND WHAT TO DO ABOUT THEM Unexpected and unlikely side effects can occur with any drug treatment. The ones listed below are particularly important for you to be aware of as they are directly related to the common actions of the drug in your treatment plan. Your doctor will review the risks of treatment and possible side effects with you before starting treatment. The chemotherapy nurse will review possible side effects of the drug and how to manage those side effects with you on the day you receive your first treatment. SERIOUS SIDE EFFETS Your white blood cells will decrease 7 10 days after your treatment. They usually return to normal 3 weeks after your last treatment. White blood cells protect your body by fighting bacteria (germs) that cause infection. When they are low, you are at greater risk of having an infection. To help prevent infection: Wash your hands often and always after using the bathroom. Take care of your skin and mouth Avoid crowds and people who are sick. all your doctor immediately at the first sign of an infection such as fever (over 100ºF or 38º by an oral thermometer), chills, cough, or burning when you pass urine. B ancer Agency Protocol Summary (Patient Version) GIA 2/5

SERIOUS SIDE EFFETS Your platelets may decrease during or after your treatment. They will return to normal after your last treatment. Platelets help to make your blood clot when you hurt yourself. You may bruise or bleed more easily than usual. Doxorubicin burns if it leaks under the skin. Nausea and vomiting may occur after your treatment and may last for 24 hours. Diarrhea may occur. To help prevent bleeding problems: Try not to bruise, cut, or burn yourself. lean your nose by blowing gently. Do not pick your nose. Avoid constipation. Brush your teeth gently with a soft toothbrush as your gums may bleed more easily. Maintain good oral hygiene. Some medications such as ASA (e.g. ASPIRIN ) or ibuprofen (e.g. ADVIL ) may increase your risk of bleeding. Do not stop taking any medication that has been prescribed by your doctor (e.g. ASA for your heart). For minor pain, try acetaminophen (e.g. TYLENOL ) first, but occasional use of ibuprofen may be acceptable. Tell your nurse or doctor immediately if you feel burning, stinging, or any other changes while the drug is being given. You will be given a prescription for an antinausea drug(s) to take before your chemotherapy treatment and/or at home. It is easier to prevent nausea than treat it once it has occurred, so follow directions closely. Drink plenty of liquids. Eat and drink often in small amounts. Try the ideas in the Practical Tips to Help Manage Nausea* To help diarrhea: Drink plenty of liquids. Eat and drink often in small amounts Avoid high fibre foods as outlined in Food Ideas to Help Manage Diarrhea* B ancer Agency Protocol Summary (Patient Version) GIA 3/5

OTHER SIDE EFFETS Pain or tenderness may occur where the needle was placed. Your urine may be pink or reddish for 1-2 days after your treatment. Sore mouth may occur a few days after treatment. Mouth sores can occur on the tongue, the sides of the mouth or in the throat. Mouth sores or bleeding gums can lead to an infection. Hair loss is common and may begin within a few days or weeks of treatment. Your hair may thin or you may become totally bald. Your scalp may feel tender. You may lose hair on your face and body. Your hair will grow back once your treatments are over and sometimes between treatments. olour and texture may change. Your skin may darken in some areas such as your nails, soles or palms. Loss of appetite and weight loss are common and may persist long after discontinuation of doxorubicin. Apply cool compresses or soak in cool water for 15 20 minutes several times a day. This is expected as doxorubicin is red and is passed in your urine. Brush your teeth gently after eating and at bedtime with a very soft toothbrush. If your gums bleed, use gauze instead of a brush. Use baking soda instead of toothpaste. Make a mouthwash with ½ teaspoon baking soda or salt in 1 cup warm water and rinse several times a day. Try soft, bland foods like puddings, milkshakes and cream soups. Avoid spicy, crunchy or acidic food, and very hot or cold foods. Try ideas in Food Ideas to Try with a Sore Mouth*. Refer to For the Patient: Hair Loss Due to hemotherapy.* You may also want to: Apply mineral oil to your scalp to reduce itching. If you lose your eyelashes and eyebrows, protect your eyes from dust and grit with a broad-rimmed hat and glasses. This will slowly return to normal once you stop treatment with doxorubicin. Try the ideas in Food Ideas to Help with Decreased Appetite.* *Please ask your chemotherapy nurse, pharmacist, or dietician for a copy INSTRUTIONS FOR THE PATIENT Tell your doctor if you have ever had an unusual or allergic reaction to doxorubicin, daunorubicin, epirubicin, idarubicin, mitomycin or mitoxantrone before treatment begins. The drinking of alcohol (in small amounts) does not appear to affect the safety or usefulness of doxorubicin. Doxorubicin may cause sterility in men and menopause in women. If you plan to have children, discuss this with your doctor before being treated with doxorubicin. Doxorubicin may damage sperm and may harm the baby if used during pregnancy. It is best to use birth control while being treated with doxorubicin. Tell your doctor right away if you or your partner becomes pregnant. Do not breast feed during treatment. Tell doctors, dentists, and other health professionals that you are being treated with doxorubicin before you receive any treatment from them. B ancer Agency Protocol Summary (Patient Version) GIA 4/5

Medication Interactions Other drugs such as digoxin (LANOXIN ) and cyclosporine (NEORAL, SANDIMMUNE ) may interact with doxorubicin. Tell your doctor if you are taking either of these or any other drugs as you may need extra blood tests or your dose may need to be changed. heck with your doctor or pharmacist before you start taking any new drugs. THE FOLLOWING INFORMATION IS VERY IMPORTANT SEE YOUR DOTOR OR GET EMERGENY HELP IMMEDIATELY IF YOU HAVE: Signs of heart problems such as fast or uneven heartbeat, chest pain, chest pressure, shortness of breath or difficulty breathing, swelling of ankles or fainting. Signs of an infection such as fever (over 100 F or 38 by an oral thermometer); chills; cough; pain or burning when you pass urine. Signs of bleeding problems such as black, tarry stools; blood in urine or stools; pinpoint red spots on skin, extensive bruising. Signs of an allergic reaction (rare) soon after a treatment including dizziness, fast heart beat, face swelling or breathing problems. SEE YOUR DOTOR AS SOON AS POSSIBLE (DURING OFFIE HOURS) IF YOU HAVE: Severe skin reaction where you have had radiation. Signs of gout such as joint pain. hanges in eyesight. Skin rash or itching. HEK WITH YOUR DOTOR IF ANY OF THE FOLLOWING ONTINUE OR BOTHER YOU: Uncontrolled nausea, vomiting or diarrhea. Easy bruising or minor bleeding. Redness, swelling, pain or sores where the needle was placed. Redness, swelling, pain or sores on your lips, tongue, mouth or throat. If you experience symptoms or changes in your body that have not been described above but worry you, or if any symptoms are severe, contact: at telephone number: B ancer Agency Protocol Summary (Patient Version) GIA 5/5